Expanded Access for CC-2001

A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease

NCT00002110 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

NCT04334915 ·Status: WITHDRAWN ·Phase: PHASE2

Viracept Expanded Access Program

NCT00002165 ·Status: COMPLETED ·Phase: NA

An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies

NCT00002118 ·Status: COMPLETED ·Phase: NA

Triage Survey for Infectious Disease Eligibility

NCT06492187 ·Status: RECRUITING

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

NCT00708110 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

NCT00005921 ·Status: COMPLETED ·Phase: NA

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

NCT00397566 ·Status: WITHDRAWN ·Phase: PHASE2

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

NCT00046332 ·Status: COMPLETED ·Phase: PHASE2

Expanded Access for Mezigdomide

NCT06994117 ·Status: AVAILABLE

The SwissPrEPared Study

NCT03893188 ·Status: RECRUITING

Safety and Tolerability of Z-100 in Patients With Early HIV Infection

NCT00016692 ·Status: TERMINATED ·Phase: PHASE1

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

NCT00000812 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2

The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex

NCT00001011 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

NCT00002117 ·Status: COMPLETED ·Phase: PHASE3

Dasatinib for HIV-1 Reservoir Reduction

NCT07342491 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Daclizumab to Treat HIV-Infected Patients

NCT00080431 ·Status: COMPLETED ·Phase: PHASE1

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

NCT00002033 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals

NCT00000736 ·Status: COMPLETED ·Phase: PHASE3

Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E

NCT00002094 ·Status: COMPLETED ·Phase: NA

A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)

NCT00001006 ·Status: COMPLETED ·Phase: PHASE1

Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children

NCT01031082 ·Status: COMPLETED

Project SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A Nurse-driven Protocol

NCT07346508 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium

NCT00001081 ·Status: COMPLETED ·Phase: PHASE2